Abiraterone In Vitro Is Superior to Enzalutamide in Response to Ionizing Radiation

Abiraterone acetate and Enzalutamide are novel anti-androgens that are key treatments to improve both progression-free survival and overall survival in patients with metastatic castration-resistant prostate cancer. In this study, we aimed to determine whether combinations of AR inhibitors with radia...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Timothy C., Dunne, Victoria L., Alshehri, Ali H. D., Redmond, Kelly M., Cole, Aidan J., Prise, Kevin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335570/
https://www.ncbi.nlm.nih.gov/pubmed/34367984
http://dx.doi.org/10.3389/fonc.2021.700543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335570/
https://www.ncbi.nlm.nih.gov/pubmed/34367984
http://dx.doi.org/10.3389/fonc.2021.700543

Ejemplares similares